Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element

Journal of Clinical Investigation

Volumn 109, Issue 7, 2002, Pages 961-971

  Claudel, Thierry ^a   Sturm, Ekkehard ^b   Duez, Hélène ^a   Torra, Inés Pineda ^a   Sirvent, Audrey ^c   Kosykh, Vladimir ^d   Fruchart, Jean Charles ^a   Dallongeville, Jean ^a   Hum, Dean W ^c   Kuipers, Folkert ^b   Staels, Bart ^a  

^a INSERM   (France)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Genfit SA   (France)

^d INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BILE ACID; CELL NUCLEUS RECEPTOR; FARNESOID X RECEPTOR; HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; FEMALE; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; RISK FACTOR; TRANSCRIPTION REGULATION;

EID: 0036218724     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214505     Document Type: Article

References (60)

1. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease
2. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
3. Pharmacology of apolipoprotein A-I
4. Structure, function and regulation of the ABC1 gene product
5. Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit
6. Molecular mechanisms of reverse cholesterol transport
7. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
8. Identification of a nuclear receptor that is activated by farnesol metabolites
9. Isolation of proteins that interact specifically with the retinoid X receptor: Two novel orphan receptors
10. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor
11. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
12. Identification of a nuclear receptor for bile acids
13. Bile acids: Natural ligands for an orphan nuclear receptor
14. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
15. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
16. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer
17. Substrate specificity of the ileal and the hepatic Na(+)/bile acid cotransporters of the rabbit. I. Transport studies with membrane vesicles and cell lines expressing the cloned transporters
18. Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor
19. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
20. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
21. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
22. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition
23. Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine
24. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat
25. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones
26. Treatment of cerebrotendinous xanthomatosis: Effects of chenodeoxycholic acid, pravastatin, and combined use
27. Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
28. A fluorimetric and enzymatic method for the estimation of serum total bile acids
29. Parameters of lipoprotein metabolism and cholestasis in healthy and cholestatic infants and children
30. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses
31. Isolation and culturing of hepatocytes from human liver
32. Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells
33. Identification of a chemical tool for the orphan nuclear receptor FXR
34. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
35. Perturbation of developmental gene expression in rat liver by fibric acid derivatives: Lipoprotein lipase and alpha-fetoprotein as models
36. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium
37. Negative regulation of the human apolipoprotein A-I promoter by fibrates can be attenuated by the interaction of the peroxisome proliferator-activated receptor with its response element
38. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
39. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter
40. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR
41. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
42. Down-regulation of cholesterol 7alpha-hydroxylase (CYP7A1) gene expression by bile acids in primary rat hepatocytes is mediated by the c-jun N-terminal kinase pathway
43. Progressive familial intrahepatic cholestasis: Partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients
44. Apolipoprotein A-I containing lipoproteins in coronary artery disease
45. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
46. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin
47. Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes
48. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors
49. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences
50. The alpha 1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family
51. CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene
52. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily
53. Hep G2 cells: A model for studies on regulation of human cholesterol 7alpha-hydroxylase at the molecular level
54. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers
55. The RXK heterodimers and orphan receptors
56. Transcriptional repression by thyroid hormone receptors. A role for receptor homodimers in the recruitment of SMRT corepressor
57. The effects of dexamethasone on in vitro collagen gene expression
58. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
59. Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion
60. Intracellular receptors use a common mechanism to interpret signaling information at response elements